Considerations for laxatives in terms of their interactions with other drugs.

IF 3.9 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Expert Opinion on Drug Metabolism & Toxicology Pub Date : 2023-03-01 DOI:10.1080/17425255.2023.2193326
Gabrio Bassotti, Edda Battaglia
{"title":"Considerations for laxatives in terms of their interactions with other drugs.","authors":"Gabrio Bassotti, Edda Battaglia","doi":"10.1080/17425255.2023.2193326","DOIUrl":null,"url":null,"abstract":"Laxatives represent the main treatment for constipated subjects since ancient times [1], are among the most frequently used drugs worldwide, and impose a substantial economic burden on both patients and health-care systems [2]. Although the use of laxatives is generally perceived as safe in the public opinion, an important issue to take into account is that constipation increases in frequency with age and that aged subjects are those with the major consumption of drugs. This increases the risk of potentially harmful pharmacologic interactions. A significant problem in evaluating this aspect of laxatives is due to the fact that many (probably, most) constipated patients often escape the physicians’ prescription and self treat their symptoms by means of over the counter (OTC) products [3]. Of note, these products are frequently not disclosed to the caring physicians probably because OTCs are not considered as actual drugs, and their use is often strictly linked to person to person (friends, neighbors, etc.) suggestions or pharmacist’s advice. It is also extremely important to remember that many OTC products are represented by herbal formulations (often composed of different and heterogeneous substances, employed for multiple dissimilar pathological conditions) and that these may interact with laxatives [4]. Thus, there is a concrete possibility that, especially in elderly subjects and/or in those treated with multiple drug regimens, the widespread use of laxatives (including the OTC ones) could cause potential interactions with other drugs. Unfortunately, this aspect has been almost neglected by researchers. Therefore, the literature evidence on this topic is relatively scarce, and these interactions are rarely detailed or are based on single-case reports [5].","PeriodicalId":12250,"journal":{"name":"Expert Opinion on Drug Metabolism & Toxicology","volume":"19 3","pages":"121-123"},"PeriodicalIF":3.9000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Drug Metabolism & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17425255.2023.2193326","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

Laxatives represent the main treatment for constipated subjects since ancient times [1], are among the most frequently used drugs worldwide, and impose a substantial economic burden on both patients and health-care systems [2]. Although the use of laxatives is generally perceived as safe in the public opinion, an important issue to take into account is that constipation increases in frequency with age and that aged subjects are those with the major consumption of drugs. This increases the risk of potentially harmful pharmacologic interactions. A significant problem in evaluating this aspect of laxatives is due to the fact that many (probably, most) constipated patients often escape the physicians’ prescription and self treat their symptoms by means of over the counter (OTC) products [3]. Of note, these products are frequently not disclosed to the caring physicians probably because OTCs are not considered as actual drugs, and their use is often strictly linked to person to person (friends, neighbors, etc.) suggestions or pharmacist’s advice. It is also extremely important to remember that many OTC products are represented by herbal formulations (often composed of different and heterogeneous substances, employed for multiple dissimilar pathological conditions) and that these may interact with laxatives [4]. Thus, there is a concrete possibility that, especially in elderly subjects and/or in those treated with multiple drug regimens, the widespread use of laxatives (including the OTC ones) could cause potential interactions with other drugs. Unfortunately, this aspect has been almost neglected by researchers. Therefore, the literature evidence on this topic is relatively scarce, and these interactions are rarely detailed or are based on single-case reports [5].
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
考虑到泻药与其他药物的相互作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Expert Opinion on Drug Metabolism & Toxicology
Expert Opinion on Drug Metabolism & Toxicology 医学-生化与分子生物学
CiteScore
7.90
自引率
2.30%
发文量
62
审稿时长
4-8 weeks
期刊介绍: Expert Opinion on Drug Metabolism & Toxicology (ISSN 1742-5255 [print], 1744-7607 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. The Editors welcome: Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data. Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug. The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.
期刊最新文献
A critical need for ‘gut neutrality’: mitigating adverse drug-microbiome interactions Drug interactions in cardiology: focus on statins and their combination with other lipid-lowering drugs Assessing the therapeutic and toxicological profile of novel GLP-1 receptor agonists for type 2 diabetes Clinical pharmacokinetics of glipizide: a systematic review Intraocular drugs: pharmacokinetic strategies and the influence on efficacy and durability.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1